Medicine & Health

School of Medicine scientists have received a five-year $11.7 million grant to study human genes and nerve cells to better understand how cells transmit pain and to find new ways to treat it.

A study from Washington University School of Medicine shows that as patients age, Huntington’s disease impairs autophagy, which eliminates waste from cells.

Researchers at the School of Medicine are working toward a treatment for neurodegenerative diseases, among them peripheral neuropathies and Parkinson’s disease, that targets SARM1, a key molecule in the death of axons, the wiring of the nervous system.

Faculty members Song Hu and Yong Wang are teaming up to find quantitative biomarkers for clinical pain management.

Abhinav Jha and a group of interdisciplinary collaborators have developed a method to measure dopamine transporter, a protein related to movement and Parkinson’s disease.

Washington University School of Medicine faculty members Opeolu M. Adeoye, MD, Farshid Guilak, PhD, David H. Gutmann, MD, PhD, and Jonathan Kipnis, PhD, have been elected to the National Academy of Medicine, a part of the National Academy of Sciences. Membership is considered one of the highest honors in the health and medicine fields.

A $314,807 grant from the National Institutes of Health (NIH) will support Abhinav Jha’s interdisciplinary work looking at the ethics of artificial intelligence implementation in the medical sphere.

Washington University has licensed the rights to develop, manufacture and commercialize its proprietary COVID-19 nasal vaccine in the United States, Europe and Japan to Ocugen Inc., a U.S.-based biotechnology company.

Pioneering research at Washington University helped people understand the fundamental role of gut microbes in human health and disease. Now a community of local scientists is learning more about the diverse microbial systems that support animals, plants and ecosystems.

An award from Wellcome Leap will support Michelle Oyen’s study of fetal growth restriction during gestational development. The program aims to reduce stillbirth rates by half.